Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
68
CLOEF Quote, Financials, Valuation and Earnings
Last price:
$3.54
Seasonality move
:
3.19%
Day range:
$3.54 - $3.54
52-week range:
$2.40 - $3.71
Dividend yield:
3.11%
P/E ratio:
14.37x
P/S ratio:
1.19x
P/B ratio:
1.71x
Volume:
--
Avg. volume:
--
1-year change:
47.5%
Market cap:
$1B
Revenue:
$814.6M
EPS (TTM):
$0.25
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Cloetta AB has -- downside to fair value with a price target of -- per share.
CLOEF vs. S&P 500
-
Over the past 5 trading days, Cloetta AB has underperformed the S&P 500 by -0.1% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cloetta AB does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cloetta AB has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Cloetta AB reported revenues of $228.7M.
Earnings Growth
-
Cloetta AB has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Cloetta AB reported earnings per share of $0.07.
Enterprise value:
1.2B
EV / Invested capital:
1.50x
Price / LTM sales:
1.19x
EV / EBIT:
11.89x
EV / Revenue:
1.36x
PEG ratio (5yr expected):
0.23x
EV / Free cash flow:
14.56x
Price / Operating cash flow:
12.75x
Enterprise value / EBITDA:
9.37x
Gross Profit (TTM):
$287.6M
Return On Assets:
6.48%
Net Income Margin (TTM):
8.29%
Return On Equity:
12.96%
Return On Invested Capital:
9.11%
Operating Margin:
11.85%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $754.8M | $807.3M | $846.8M | $210.7M | $228.7M | |
| Gross Profit | $239.5M | $259.9M | $287.6M | $66.9M | $73.1M | |
| Operating Income | $73.6M | $80.3M | $97M | $22.8M | $27.1M | |
| EBITDA | $101.3M | $107M | $123.1M | $29.4M | $34.3M | |
| Diluted EPS | $0.13 | $0.15 | $0.25 | $0.04 | $0.07 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $273.3M | $245.7M | $286.6M | $336.9M | $322.5M | |
| Total Assets | $1.1B | $914.7M | $1B | $1.1B | $1.1B | |
| Current Liabilities | $187.5M | $158.2M | $178M | $195.7M | $220.6M | |
| Total Liabilities | $588.1M | $481.9M | $522.1M | $561.9M | $507.1M | |
| Total Equity | $502.7M | $432.8M | $478.7M | $512M | $592.4M | |
| Total Debt | $281.5M | $205.5M | $218.6M | $231M | $159M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $54.2M | $88.6M | $93.5M | $23.9M | $40.3M | |
| Cash From Investing | -$22.2M | -$13.6M | -$13.4M | -$3.1M | -$4.3M | |
| Cash From Financing | -$39.1M | -$34.9M | -$124.4M | -$1.7M | -$87.7M | |
| Free Cash Flow | $32M | $69.5M | $79.2M | $20.2M | $35.9M | |
CLOEF
Sector
Market Cap
$1B
$125M
Price % of 52-Week High
95.42%
71.8%
Dividend Yield
3.11%
0%
Shareholder Yield
4.31%
2.32%
1-Year Price Total Return
47.5%
-7.14%
Beta (5-Year)
-0.322
0.257
Dividend yield:
3.11%
Annualized payout:
$0.09
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.54
200-day SMA
Buy
Level
$3.25
Bollinger Bands (100)
Sell
Level
3.52 - 3.68
Chaikin Money Flow
Buy
Level
10.1K
20-day SMA
Sell
Level
$3.54
Relative Strength Index (RSI14)
Sell
Level
17.92
ADX Line
Sell
Level
61.92
Williams %R
Sell
Level
0
50-day SMA
Sell
Level
$3.54
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Sell
Level
-20.5K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.8419)
Buy
CA Score
(Annual)
Level (0.0825)
Buy
Beneish M-Score
(Annual)
Level (-2.7033)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (0.1051)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cloetta AB manufacturse, and markets sugar confectionery, chocolate products, pastilles, and chewing gum. It operates through the following geographical segments: Scandinavia, Sweden, Finland, Norway and Denmark, Middle, International Markets and the UK, and The Netherlands and Germany. The company was founded by Bernhard Cloetta, Christoffer Cloetta and Nutin Cloetta in 1862 and is headquartered in Sundbyberg, Sweden.
Stock Forecast FAQ
In the current month, CLOEF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CLOEF average analyst price target in the past 3 months is --.
-
Where Will Cloetta AB Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cloetta AB share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Cloetta AB?
Analysts are divided on their view about Cloetta AB share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cloetta AB is a Sell and believe this share price will rise from its current level to --.
-
What Is Cloetta AB's Price Target?
The price target for Cloetta AB over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CLOEF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cloetta AB is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CLOEF?
You can purchase shares of Cloetta AB via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cloetta AB shares.
-
What Is The Cloetta AB Share Price Today?
Cloetta AB was last trading at $3.54 per share. This represents the most recent stock quote for Cloetta AB. Yesterday, Cloetta AB closed at $3.54 per share.
-
How To Buy Cloetta AB Stock Online?
In order to purchase Cloetta AB stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CLOEF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLOEF
Sector
P/E ratio
14.37x
16.72x
PEG ratio
0.23x
0.13x
P/B ratio
1.71x
1.48x
Price / LTM sales
1.19x
0.51x
Growth Metrics
CLOEF
Sector
Revenue growth
8.56%
2.99%
Earnings growth
59.63%
5%
Revenue (5-year growth)
3.49%
3.32%
Earnings forecast
--
$0.32
Profitability
CLOEF
Sector
Profitability FY 2024
$264.3M
$263.1M
Return on invested capital
9.11%
4.48%
Return on assets
6.48%
3.08%
Return on equity
12.96%
7.59%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
4
Balance Sheet
CLOEF
Sector
Total cash
$36M
$88.7M
Short term investments
--
$32.9M
Total assets
$1B
$1.1B
Long term debt
$159M
$6.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
